Plain-English translation of NCT04888247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the HighLife CLARITY Valve, a new artificial heart valve that can be placed without open-heart surgery. Researchers want to see if it's safe and effective for people with a severely leaky mitral valve (the valve between the left chambers of the heart) who are too sick or frail for traditional surgery.
Many people with severe mitral valve leakage cannot have traditional open-heart surgery because of their age, frailty, or other serious health conditions. This trial exists to develop a less invasive option that could help these patients by replacing the faulty valve through a small tube inserted between the ribs.
You likely qualify if…
You likely don't qualify if…
You would undergo the valve replacement procedure, which is performed through a catheter (small tube) inserted between your ribs — a less invasive approach than traditional heart surgery. You would then return for regular follow-up visits to monitor how well the new valve is working and check for any side effects. The study involves about 30 patients, and you would be followed for at least 12 months after the procedure.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Australia
Belgium